Our first respiratory panel on a test cartridge
– designed for simple, reliable pathogen detection.
Detechgene offers a PCR-alternative in the form of lyophilized LAMP beads for nucleic acid detection.
Rapid on-site molecular results to support confident clinical decisions – without complex lab infrastructure.
Detect multiple pathogens in one run to enable faster, targeted treatment decisions.
Designed for decentralized use and rapid rollout with minimal infrastructure.
Rapidly adapt panels to locally relevant or emerging pathogens across sample types.
We overcome the trade-off between speed and accuracy in clinical diagnostics.
Built on nucleic acid detection, our platform architecture is designed for reliable and scalable molecular diagnostics.
Learn moreDetechgene is headquartered in Cologne and originated from the University Hospital Cologne environment, combining scientific rigor with product development.
Learn more
Together with our strong partners, we build the ecosystem to drive innovation in molecular diagnostics.
Biologist Reza Esmaillie and engineer Robin Bayer have developed a PCR test that detects not only coronaviruses, but also bacteria or fungi. With their...
As precise as a PCR test, but as fast as an antigen test: A young company from Cologne is about to launch a new type of diagnostic system. The invention...
Kölner Universitäten helfen bei der Start-Up-Gründung...
German BioTech startup Detechgene pockets €3.2 million to take lab diagnostics mobile. Detechgene, a Cologne-based BioTech startup...
Reality check for young German companies: The Cologne-based start-up Detechgene was one of the ten German...
Detechgene raises 3.2 million euros – market entry is imminent. Reza Esmaillie and Robin Bayer are developing a PCR test that detects pathogens...
Detechgene provided outstanding support in establishing quantitative qPCR methods. We were particularly impressed by the swift and efficient implementation as well as the competent scientific guidance. An impressive combination of scientific depth and practical execution.
Detechgene combines the best of both worlds: the speed of a point-of-care test with the quality assurance of a diagnostic laboratory. This integrated approach builds trust in the test result and brings reliable molecular diagnostics faster and closer to the patient.
Technologies like those developed by Detechgene bring diagnostic decisions closer to the patient. When results are transmitted in near real-time to surveillance networks like the Clinical Virology Net, this enables earlier detection of epidemiological developments and more timely assessment of infectious disease events.
